A detailed history of Rathbones Group PLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Rathbones Group PLC holds 1,283,979 shares of EW stock, worth $96.1 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
1,283,979
Previous 920,928 39.42%
Holding current value
$96.1 Million
Previous $85.1 Million 0.4%
% of portfolio
0.45%
Previous 0.48%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$59.7 - $93.78 $21.7 Million - $34 Million
363,051 Added 39.42%
1,283,979 $84.7 Million
Q2 2024

Aug 09, 2024

BUY
$84.3 - $94.31 $2.73 Million - $3.06 Million
32,422 Added 3.65%
920,928 $85.1 Million
Q1 2024

May 14, 2024

BUY
$72.54 - $95.56 $5.48 Million - $7.22 Million
75,529 Added 9.29%
888,506 $84.9 Million
Q4 2023

Feb 13, 2024

BUY
$61.71 - $77.76 $5.56 Million - $7 Million
90,025 Added 12.45%
812,977 $62 Million
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $10.1 Million - $13.5 Million
145,089 Added 25.11%
722,952 $50.1 Million
Q2 2023

Aug 04, 2023

BUY
$81.41 - $94.33 $3 Million - $3.48 Million
36,865 Added 6.81%
577,863 $54.5 Million
Q1 2023

May 12, 2023

BUY
$74.26 - $84.51 $3.6 Million - $4.1 Million
48,481 Added 9.84%
540,998 $44.8 Million
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $3.6 Million - $4.61 Million
52,724 Added 11.99%
492,517 $36.7 Million
Q3 2022

Nov 03, 2022

BUY
$82.37 - $107.29 $734,658 - $956,919
8,919 Added 2.07%
439,793 $36.3 Million
Q2 2022

Aug 12, 2022

BUY
$86.5 - $128.27 $2.48 Million - $3.67 Million
28,635 Added 7.12%
430,874 $41 Million
Q1 2022

May 11, 2022

BUY
$101.96 - $128.34 $1.03 Million - $1.3 Million
10,101 Added 2.58%
402,239 $47.4 Million
Q4 2021

Feb 10, 2022

BUY
$106.37 - $130.68 $2.77 Million - $3.4 Million
26,049 Added 7.12%
392,138 $50.8 Million
Q3 2021

Nov 04, 2021

BUY
$102.91 - $122.75 $5,042 - $6,014
49 Added 0.01%
366,089 $41.4 Million
Q2 2021

Jul 30, 2021

BUY
$83.84 - $104.76 $4.14 Million - $5.18 Million
49,435 Added 15.61%
366,040 $37.9 Million
Q1 2021

May 14, 2021

BUY
$78.68 - $90.67 $6.48 Million - $7.46 Million
82,311 Added 35.13%
316,605 $26.5 Million
Q4 2020

Feb 11, 2021

BUY
$71.69 - $91.23 $8.74 Million - $11.1 Million
121,929 Added 108.51%
234,294 $21.4 Million
Q3 2020

Nov 13, 2020

BUY
$67.19 - $87.44 $5.78 Million - $7.52 Million
86,020 Added 326.51%
112,365 $8.97 Million
Q2 2020

Aug 07, 2020

BUY
$57.54 - $76.95 $1.43 Million - $1.91 Million
24,838 Added 1648.18%
26,345 $1.82 Million
Q1 2020

May 04, 2020

BUY
$52.41 - $81.0 $78,981 - $122,067
1,507 New
1,507 $284,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Rathbones Group PLC Portfolio

Follow Rathbones Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.